Sortino ratio is not yet available for CTLT. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.
How it compares to other similar stocks
The table compares Catalent, Inc.'s Sortino Ratio with other stocks in the Drug Manufacturers - Specialty & Generic industry across multiple time periods, showing how CTLT's risk-adjusted performance compares to industry peers.
Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jun 5, 2026.
| Symbol | Name | 1Y Sortino Ratio | 5Y Sortino Ratio | 10Y Sortino Ratio | All Time Sortino Ratio |
|---|---|---|---|---|---|
| EGRX | Eagle Pharmaceuticals Inc | 6.66 | |||
| INDV | Indivior PLC Ordinary Shares | 5.59 | |||
| IRWD | Ironwood Pharmaceuticals, Inc. | 4.12 | |||
| BIOA | BioAge Labs, Inc | 4.12 | |||
| VTRS | Viatris Inc. | 3.85 | |||
| TEVA | Teva Pharmaceutical Industries Limited | 3.68 | |||
| ASRT | Assertio Holdings, Inc. | 3.56 | |||
| AMRX | Amneal Pharmaceuticals, Inc. | 3.44 | |||
| RGC | Regencell Bioscience Holdings Limited | 3.32 | |||
| CURLF | Curaleaf Holdings, Inc. | 3.05 | |||
| CTLT | Catalent, Inc. | — |
Historical Sortino Ratio
The chart shows CTLT's rolling Sortino ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to downside risk, while declining trends may signal deteriorating risk-adjusted performance or increased volatility during market stress. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.
Identify market cycles by observing when CTLT consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.
Loading charts...
IHow does CTLT fit in your portfolio?
Add your other holdings to see your portfolio's Sortino Ratio and find out.
Analyze Your Portfolio